Yuanbao Inc. American Depositary Shares (YB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yuanbao Inc. American Depositary Shares (YB) has a cash flow conversion efficiency ratio of 0.399x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.50 Billion) by net assets ($3.75 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See YB equity financing ratio to measure how much of total assets are equity-financed.
Yuanbao Inc. American Depositary Shares - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Yuanbao Inc. American Depositary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Yuanbao Inc. American Depositary Shares cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Yuanbao Inc. American Depositary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yuanbao Inc. American Depositary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
-0.147x |
|
Banestes S.A - Banco do Estado do Espírito Santo
SA:BEES3
|
-1.747x |
|
Gruvaktiebolaget Viscaria
ST:VISC
|
-0.018x |
|
Sinosun Tech
SHE:300333
|
-0.011x |
|
Dingli Communications Corp Ltd
SHE:300050
|
0.082x |
|
AdvanSix Inc
NYSE:ASIX
|
0.032x |
|
Fenix Outdoor International AG
ST:FOI-B
|
-0.029x |
|
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT
|
-0.084x |
Annual Cash Flow Conversion Efficiency for Yuanbao Inc. American Depositary Shares (2021–2025)
The table below shows the annual cash flow conversion efficiency of Yuanbao Inc. American Depositary Shares from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Yuanbao Inc. American Depositary Shares.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.35 Billion | $1.50 Billion | 0.447x | +160.45% |
| 2024-12-31 | $-1.63 Billion | $1.21 Billion | -0.739x | -257.45% |
| 2023-12-31 | $-2.14 Billion | $441.97 Million | -0.207x | -343.26% |
| 2022-12-31 | $-1.88 Billion | $87.72 Million | -0.047x | -128.45% |
| 2021-12-31 | $-1.49 Billion | $-244.99 Million | 0.164x | -- |
About Yuanbao Inc. American Depositary Shares
Yuanbao Inc., together with its subsidiaries, provides insurance brokerage and agency licenses services in the People's Republic of China. The company offers medical, critical illness, accident, property, and pet insurance products. Yuanbao Inc. was incorporated in 2019 and is headquartered in Beijing, the People's Republic of China.